Hyperuricosuric Calcium Urolithiasis
The term “normocalciuric nephrolithiasis” 1 was initially used to describe patients with recurrent Ca urolithiasis in whom a 24-hr urinary Ca was within the normal range. This condition may be subdivided into the different groups listed in Table VIII. Absorptive hypercalciuria Type II was discussed in Chapter 3. Hyperoxaluria will be covered in Chapter 6. The idiopathic group comprises those patients in whom there is no obvious abnormality for stone formation. Some of these patients give a history of low fluid intake. In others, the formation product ratios (FPRs) (limit of metastability) of brushite and Ca oxalate in urine may be significantly reduced. 2 Thus, urinary supersaturation with respect to Ca salts, resulting from the passage of concentrated urine, and deficiency of inhibitors or presence of promoters of nucleation, or both, may be etiologically important in stone formation in the idiopathic group. This chapter will focus principally on Ca stone formation associated with hyperuricosuria.
KeywordsCreatinine Gall Oxalate Purine Gout
Unable to display preview. Download preview PDF.
- 10.Barilla, D. E., and Pak, C. Y. C. 1977. In preparation.Google Scholar
- 11.Smith, M. J. V. 1977. Placebo vs. allopurinol for renal calculi. J. Urol. In press.Google Scholar
- 14.Robertson, W. G., Peacock, M., and Nordin, B. E. C. 1971. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clin. Sci. (Oxford) 40: 365–374.Google Scholar
- 19.Lonsdale, K. 1968. Epitaxy as a growth factor in urinary calculi and gallstones. Nature (London) 217: 56–58.Google Scholar
- 20.Zerwekh, J., and Pak, C. Y. C. 1977. In preparation.Google Scholar
- 23.Coe, F. L. 1977. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. Submitted for publication.Google Scholar
- 24.Coe, F. L. 1976. Long term prevention of calcium oxalate nephrolithiasis by chronic thiazide and allopurinol administration. Clin. Res. 24: 396A.Google Scholar